Scilex Holding Company

Direct answer

Scilex Holding Company is publicly traded on NASDAQ under the ticker SCLX.

Scilex Holding Company is a biopharmaceutical enterprise that specializes in the development and market introduction of non-opioid therapies designed to alleviate both acute and chronic pain. Its primary marketed offering is ZTlido 1.8%, a topical prescription formulation of lidocaine specifically engineered to mitigate neuropathic discomfort associated with post-herpetic neuralgia, a condition characterized by...

Can you invest in Scilex Holding Company?

Yes. Scilex Holding Company is publicly traded on NASDAQ under the ticker SCLX.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Scilex Holding Company

Detailed equity research is provided by MarketSnap.